Sign in
CompletedPhase 1

Evaluation of the Role of Acetyl Cysteine in Ventilator Associated Pneumonia by Carbapenem Resistance Klebsiella

Key facts

Who runs it
Tanta University
Where
Egypt1 site in 1 countryChoose a country to see its sites
Trial code
Status
Completed
Phase
Phase 1
People taking part
70 people enrolled
Started
30 Oct 2023
Ended
30 Oct 2024
Type of study
Interventional, 2 groups
Treatments tested
  • acetyl cysteine 600 mg
  • antibiotics and saline.
Record updated
31 July 2025

Who can take part

Age
21 years to 65 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 9 criteriaShow less

Who can take part

  • Patients who are mechanically ventilated
  • Age from 21 to 65
  • Both sexes

Who cannot take part

  • Patients on steroid or immunosuppressive drugs
  • Patient guardians who refuse the consent • Hypersensitivity to acetyl Cysteine
  • Extrapulmonary infection
  • Cardiac patient with chronic heart failure
  • Patient with lung diseases (tumors, tuberculosis, ,Chronic Obstructive Pulmonary Disease, Bronchiectasis and lung fibrosis)
  • Severe immunosuppression (total leucocyte < 1000 mm3 or neutrophil < 500 cell/mm3

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The aim of the study is to evaluate the role of addition of Acetyl cysteine in the management of VAP induced by carbapenem resistant klebsiella. The primary outcome indicator is the change in modified clinical pulmonary infection score. The secondary outcome indicator is duration of mechanical ventilation.

The 2 groups in the trial

  • acetyl cysteine 600 mgTreatment being tested

    patients received acetyl cysteine 600 mg/ 12h IV in addition to antibiotics

  • antibiotics and salineTreatment being tested

    patients received only antibiotics and saline.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Evaluation of the Role of Acetyl Cysteine in The Treatment of Ventilator Associated Pneumonia Induced by Carbapenem Resistance Klebsiella
Record updated
31 July 2025